Cargando…
Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure
We previously demonstrated that transient stromal cell-derived factor-1 alpha (SDF-1) improved cardiac function when delivered via cell therapy in ischemic cardiomyopathy at a time remote from acute myocardial infarction (MI) rats. We hypothesized that non-viral gene transfer of naked plasmid DNA-ex...
Autores principales: | Sundararaman, S, Miller, T J, Pastore, J M, Kiedrowski, M, Aras, R, Penn, M S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169804/ https://www.ncbi.nlm.nih.gov/pubmed/21472007 http://dx.doi.org/10.1038/gt.2011.18 |
Ejemplares similares
-
Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial
por: Chung, Eugene S., et al.
Publicado: (2015) -
In the heart of cardiac stromal senescence
por: Douin-Echinard, Victorine, et al.
Publicado: (2020) -
Bone Marrow SSEA1+ Cells Support the Myocardium in Cardiac Pressure Overload
por: Finan, Amanda, et al.
Publicado: (2013) -
Transient Myocardial Thickening in Cats Associated with Heart Failure
por: Novo Matos, J., et al.
Publicado: (2017) -
Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers
por: Luke, J M, et al.
Publicado: (2010)